Hub-and-Spoke centralized intervention to optimize colorectal cancer screening and follow-up: A pragmatic, cluster-randomized controlled trial protocol

Contemp Clin Trials. 2023 Nov:134:107353. doi: 10.1016/j.cct.2023.107353. Epub 2023 Oct 5.

Abstract

Background: Guidelines recommend screening for colorectal cancer (CRC), but participation and abnormal test follow up rates are suboptimal, with disparities by demography. Evidence-based interventions exist to promote screening, but community adoption and implementation are limited.

Methods: The San Diego Accelerating Colorectal Cancer Screening and Follow-up through Implementation Science (ACCSIS) program is an academic-community partnership testing regional implementation of a Hub-and-Spoke model for increasing CRC screening and follow-up. The "hub" is a non-academic, non-profit organization that includes 17 community health center (CHC) systems, serving over 190 rural and urban clinic sites. The "spokes" are 3 CHC systems that oversee 11-28 clinics each, totaling over 60 clinics. Using a cluster-randomized trial design, 9 clinics were randomized to intervention and 16 to usual care. Within intervention clinics, approximately 5000 eligible patients not up-to-date with CRC screening per year were identified for intervention. Interventions include an invitation primer, a mailed fecal immunochemical test with completion instructions, and phone and text-based reminders (hub) and patient navigation protocol to promote colonoscopy completion after abnormal FIT (spoke). Outcomes include: 1) proportion of patients up-to-date with screening after three years in intervention versus non-intervention clinics; 2) proportion of patients with abnormal FIT completing colonoscopy within six months of the abnormal result. Implementation science measures are collected to assess acceptability, intervention and usual care adaptations, and sustainability of the intervention strategies.

Conclusion: This large-scale, regional cluster randomized trial among CHCs serving diverse populations is anticipated to accelerate progress in CRC prevention in underserved populations.

Trial registration: NCT04941300.

Keywords: Abnormal fecal immunochemical test follow-up; Cancer disparities; Colorectal cancer screening; Community health centers.

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Ambulatory Care Facilities
  • Colorectal Neoplasms* / diagnosis
  • Community Health Centers
  • Early Detection of Cancer* / methods
  • Humans
  • Mass Screening / methods
  • Occult Blood
  • Randomized Controlled Trials as Topic

Associated data

  • ClinicalTrials.gov/NCT04941300